Safety and efficacy of subcutaneous ianalumab (VAY736) in patients with primary Sjögren's syndrome: a randomised, double-blind, placebo-controlled, phase 2b dose-finding trial
Titel:
Safety and efficacy of subcutaneous ianalumab (VAY736) in patients with primary Sjögren's syndrome: a randomised, double-blind, placebo-controlled, phase 2b dose-finding trial
Auteur:
Bowman, Simon J Fox, Robert Dörner, Thomas Mariette, Xavier Papas, Athena Grader-Beck, Thomas Fisher, Benjamin A Barcelos, Filipe De Vita, Salvatore Schulze-Koops, Hendrik Moots, Robert J Junge, Guido Woznicki, Janice N Sopala, Monika A Luo, Wen-Lin Hueber, Wolfgang